期刊
ANTIBIOTICS-BASEL
卷 10, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/antibiotics10091095
关键词
antimicrobial peptides; antibiotic resistance; multidrug resistance; ESKAPE
资金
- Assistance Publique-Hopitaux de Paris
- University Paris-Saclay
- Institut National de la Santeet de la Recherche Medicale (INSERM)
- LaboratoryFigure 3
- Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT) through a grant from the French National Research Agency [ANR-10-LABX-33]
- ANR-BMBF FrenchGerman bilateral project Natural-Arsenal New Antibiotics Tackling mUlti-Resistance by acting on Alternative bacteriaL tARgets in ynergy with mEmbrane-disruptiNg AntimicrobiaL peptides [ANR-19-AMRB-0004]
Antimicrobial peptides are a promising alternative to antibiotics for treating bacterial infections, especially those caused by multidrug-resistant pathogens. They show various activity spectra and mechanisms of actions, and can be used synergistically against ESKAPE bacteria, particularly in biofilm treatments. Challenges and limitations in their therapeutic applications are highlighted, with potential solutions being evaluated to determine if antimicrobial peptides could potentially replace antibiotics in the future.
Antimicrobial peptides constitute one of the most promising alternatives to antibiotics since they could be used to treat bacterial infections, especially those caused by multidrug-resistant pathogens. Many antimicrobial peptides, with various activity spectra and mechanisms of actions, have been described. This review focuses on their use against ESKAPE bacteria, especially in biofilm treatments, their synergistic activity, and their application as prophylactic agents. Limitations and challenges restricting therapeutic applications are highlighted, and solutions for each challenge are evaluated to analyze whether antimicrobial peptides could replace antibiotics in the near future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据